BCI’s clinical experience with HCQ received international recognition

The clinical experience of the Bulgarian Cardiac Institute for prevention and treatment of COVID-19 with hydroxychloroquine (HCQ) received international recognition. New Microbes and New Infections is a leading scientific journal publishing influential medical achievements in infectious diseases.

You can find the original article here.